Literature DB >> 21625998

Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion.

Laura Cannella, Roberto Latagliata, Massimo Breccia, Ida Carmosino, Giuseppina Loglisci, Paola Volpicelli, Antonietta Ferretti, Michelina Santopietro, Federico Vozella, Corrado Girmenia, Mariella Cuzzola, Esther Natalie Oliva, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21625998     DOI： 10.1007/s00277-011-1263-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

1.  Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy.

Authors:  Pasquale Niscola; Andrea Tendas; Laura Scaramucci; Roberta Merola; Gianfranco Catalano; Paolo de Fabritiis
Journal:  Blood Res       Date:  2014-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.